Betamethasone sodium phosphate/Fradiomycin sulfate

倍他米松磷酸钠/硫酸新霉素

Report date: 2026/03/23 20:03:44

Base Information

Drug NameBetamethasone sodium phosphate/Fradiomycin sulfate
Drug Alias NameBetamethasone disodium phosphate/Fradiomycin sulfateBetamethasone disodium phosphate/neomycin sulfateBetamethasone sodium phosphate/neomycin sulfateRinderon-A臨得隆 +[6] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonistsBacterial penicillin-binding protein inhibitors
TargetsGlucocorticoid receptorBacterial penicillin-binding protein
Therapy Area/IndicationsOcular inflammationEczemaDermatitis +[4] 
Global Approved IndicationsOcular inflammationEczemaDermatitis +[4] 
Approved Indications in ChinaDermatitis
Original Approved Country/TerritoryJapan
Original Approved Date1966/01/01
Country/TerritoryMainland ChinaJapan
CombinationsYes Fradiomycin sulfateBetamethasone
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShionogi Pharma Co LtdZhuhai Federal Pharmaceutical Co Ltd Beijing Office
Inactive CompaniesN/A
Active IndicationsOcular inflammationEczemaDermatitis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeS01BB04S01CA05S03CA06
Related LinksN/A